Status:
UNKNOWN
The Impact of an Epidural Ropivacaine-Neostigmine Injection for Perineal Analgesia at the End of Labor.
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions:
Pregnancy
Vaginal Delivery
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Perineal pain after childbirth occurs in the majority of women (with or without episiotomy). Perineal pain can become source of chronic pain in 9%-12% of the cases. Neostigmine a cholinesterase inhibi...
Detailed Description
The goal of epidural analgesia during labour is to obtain an analgesia with a minimum of "motor block". Absence of motor block at the time of the childbirth allows to decrease the rate of instrumentat...
Eligibility Criteria
Inclusion
- any parturient of 18-45 years
- normal pregnancy
- at full term
- having an effective epidural anesthesia during labor
Exclusion
- multiple pregnancy
- obstetric pathology
- refusal of participation
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
End Date :
October 1 2006
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00407290
Start Date
March 1 2006
End Date
October 1 2006
Last Update
December 5 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques Universitaires Saint Luc
Brussels, Brusssels, Belgium, 1200